Robert L. Zerbe M.D.
CIK: 0001220363
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Vericel Corp
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Apr 29, 2026VCEL
Vericel Corp
Exercise(M)Direct3.2K shares- - Apr 29, 2026VCEL
Vericel Corp
Award(A)DirectRestricted Stock Unit
3.2K shares- - Apr 29, 2026VCEL
Vericel Corp
Award(A)DirectStock Option (Right to Buy)
8K shares- - Apr 30, 2025VCEL
Vericel Corp
Exercise(M)Direct3.2K shares- - Apr 30, 2025VCEL
Vericel Corp
Award(A)DirectStock Option (Right to Buy)
8K shares- - Apr 30, 2025VCEL
Vericel Corp
Award(A)DirectRestricted Stock Unit
3.2K shares- - Feb 5, 2025VCEL
Vericel Corp
Sale(S)Direct2.5K shares at avg. $62.50$156K - Feb 5, 2025VCEL
Vericel Corp
Exercise(M)Direct2.5K shares at avg. $13.05$33K - Nov 22, 2024VCEL
Vericel Corp
Sale(S)Direct2.5K shares at avg. $60.00$150K - Nov 22, 2024VCEL
Vericel Corp
Exercise(M)Direct2.5K shares at avg. $13.05$33K - Nov 12, 2024VCEL
Vericel Corp
Exercise(M)Direct2.5K shares at avg. $13.05$33K - Nov 12, 2024VCEL
Vericel Corp
Sale(S)Direct2.5K shares at avg. $57.50$144K - Nov 11, 2024VCEL
Vericel Corp
Sale(S)Direct2.5K shares at avg. $55.00$138K - Nov 11, 2024VCEL
Vericel Corp
Exercise(M)Direct2.5K shares at avg. $13.05$33K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 29, 2026 | VCEL Vericel Corp | Exercise(M) | 3,200 | - | $0 | Direct |
| Apr 29, 2026 | VCEL Vericel Corp | Award(A) Restricted Stock Unit | 3,200 | - | - | Direct |
| Apr 29, 2026 | VCEL Vericel Corp | Award(A) Stock Option (Right to Buy) | 8,000 | - | - | Direct |
| Apr 30, 2025 | VCEL Vericel Corp | Exercise(M) | 3,200 | - | - | Direct |
| Apr 30, 2025 | VCEL Vericel Corp | Award(A) Stock Option (Right to Buy) | 8,000 | - | - | Direct |
| Apr 30, 2025 | VCEL Vericel Corp | Award(A) Restricted Stock Unit | 3,200 | - | - | Direct |
| Feb 5, 2025 | VCEL Vericel Corp | Sale(S) | 2,500 | $62.50 | $156,250 | Direct |
| Feb 5, 2025 | VCEL Vericel Corp | Exercise(M) | 2,500 | $13.05 | $32,625 | Direct |
| Nov 22, 2024 | VCEL Vericel Corp | Sale(S) | 2,500 | $60.00 | $150,000 | Direct |
| Nov 22, 2024 | VCEL Vericel Corp | Exercise(M) | 2,500 | $13.05 | $32,625 | Direct |
| Nov 12, 2024 | VCEL Vericel Corp | Exercise(M) | 2,500 | $13.05 | $32,625 | Direct |
| Nov 12, 2024 | VCEL Vericel Corp | Sale(S) | 2,500 | $57.50 | $143,750 | Direct |
| Nov 11, 2024 | VCEL Vericel Corp | Sale(S) | 2,500 | $55.00 | $137,500 | Direct |
| Nov 11, 2024 | VCEL Vericel Corp | Exercise(M) | 2,500 | $13.05 | $32,625 | Direct |
1-14 of 14 transactions
About ZERBE ROBERT L MD
ZERBE ROBERT L MD (SEC CIK 0001220363) files insider reports with the SEC as Director of Vericel Corp (VCEL).
Signal8 holds 5 ownership filings by ZERBE ROBERT L MD, all Form 4s, filed between Nov 13, 2024 and May 1, 2026. Those filings report 14 transactions, from Nov 11, 2024 to Apr 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on ZERBE ROBERT L MD's filings is in CAMBRIDGE, MA.
Recent filings by ZERBE ROBERT L MD
- Apr 29, 2026: Option exercise of VCEL shares (Form 4, code M).
- Apr 29, 2026: Grants or awards of VCEL derivative securities (2 lines, Form 4, code A).
- Apr 30, 2025: Option exercise of VCEL shares (Form 4, code M).
- Apr 30, 2025: Grants or awards of VCEL derivative securities (2 lines, Form 4, code A).
- Feb 5, 2025: Open-market sale of VCEL shares (Form 4, code S).
Other insiders filing for Vericel Corp (VCEL)
- MCLAUGHLIN KEVIN F, Director
- Halpin Michael, Chief Operating Officer
- Flynn Sean C., Chief Legal Officer
- Hopper Jonathan Mark, Chief Medical Officer
- Wotton Paul K, Director
- Mara Joseph Anthony Jr, Chief Financial Officer